Spanish Breast Cancer Research Group
Clinical trials sponsored by Spanish Breast Cancer Research Group, explained in plain language.
-
New drug tested for Tough-to-Treat breast cancer that returns quickly
Disease control TerminatedThis study aimed to test a drug called Trastuzumab Deruxtecan (T-DXd) for people with advanced HER2-positive breast cancer whose cancer returned within a year of finishing prior treatment. The goal was to see if the drug could shrink tumors and control the disease. The study was …
Phase: PHASE2 • Sponsor: Spanish Breast Cancer Research Group • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug cocktail tested for Tough-to-Treat breast cancer
Disease control TerminatedThis study tested a combination of three drugs—trastuzumab, tucatinib, and vinorelbine—for people with advanced HER2-positive breast cancer that cannot be removed by surgery or has spread. The goal was to see if this combination could shrink tumors and control the disease for peo…
Phase: PHASE2 • Sponsor: Spanish Breast Cancer Research Group • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC